Motif BioSciences' Series C Round

Motif BioSciences raised a round of funding on April 06, 2007. Investors include Amphion Innovations PLC..

Motif BioSciences is developing novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant bacteria. Motif has a lead antibiotic candidat…

Articles about Motif BioSciences' Series C Round: